|
369 Children’s
NSF sets out a big role for pharmacists Pharmacists in England
will have a significant role to play in delivering the National Service
Framework for Children, Young People and Maternity Services, announced
by the Department of Health this week ...more
369 Minister tells PCTs that the new contract will be a “watershed” for community pharmacy Health
minister Rosie Winterton delivered a positive speech about the future
of community pharmacy and the new pharmacy contract at an NHS Confederation
conference in London ...more
369 Principles
for accreditation in new contract outlined In order to provide
advanced services in the second tier of the new community pharmacy contract,
pharmacy premises and pharmacists will have to be accredited ...more
370 Hospital
pharmacists urged to keep an eye on pensions Hospital pharmacists
are being urged to keep track of the Government review of NHS pensions
and report back any changes that they fear may leave them worse off ...more
370 MPs
table motion to oppose contract liberalisation Worried members
of Parliament who believe that Government plans to exempt from contract
controls new pharmacies in large shopping developments and internet pharmacies,
among others, have tabled a critical motion in the House of Commons ...more
370 Wales
agrees to same new contract model as England Wales will use
the same model for the new community pharmacy contract as has been agreed
in England, it was confirmed this week ...more
370 Pharmacy2U
offers pharmacy affiliation service Pharmacy2U, an internet
pharmacy, is offering to co-brand pharmacy websites belonging to conventional
bricks-and-mortar pharmacies as a way of defending themselves against
new internet start-ups ...more
370 Retail
staff cuts needed in some pharmacy companies Community pharmacy
companies that spend too much on pay need to shed staff to remain competitive,
according to the latest Plimsoll portfolio analysis ...more
370 Latest
BNF published BNF 48, the latest edition of the British National
Formulary, breaks new ground by including advice on oral and dental problems
and how these relate to other problems ...more
371 New
draft Mental Health Bill published last week Mental health legislation has risen to the top of the Parliamentary agenda again with last week’s publication of a revised Mental Health Bill. The draft has been substantially revised following vigorous opposition to a first draft published two years ago
...more
371 Bath
University to investigate supplementary prescribing The University
of Bath has been awarded a Pharmacy Practice Research Trust grant to
investigate supplementary prescribing ...more
371 Update
on 2004 flu campaign Children who spent time in hospital last winter because of a respiratory infection are to be included for the first time in this year’s influenza immunisation programme. Health care workers are also being targeted for the second year running in the campaign that will be officially launched on 4 October
...more
371 Pharmacists
promote medicines management at local shows ...more
372 Pharmacists
test blood pressure across the UK Pharmacists across the UK
played a leading role this week in a campaign to persuade people to have
their blood pressure checked ...more
372 Lloyds
says think before buying vitamins A pharmacy chain is behind
a national television advertising campaign to encourage people to think
twice before taking vitamin supplements ...more
372 Patient
dies after pharmacy fails to supply medicine Lack of treatment because a drug was out of stock contributed to a man’s death at Plymouth’s Derriford Hospital last year, an inquest jury has ruled
...more
372 FIP
launches weblogs to spread best practice A global pharmacy
weblogs site has been launched by the Community Pharmacy Section and
the Young Pharmacists Group of the International Pharmaceutical Federation
in association with the Pharmaceutical Services Negotiating Committee
...more
|
373 Letrozole
another option after tamoxifen therapy Postmenopausal women
with early breast cancer who have completed standard adjuvant tamoxifen
therapy now have the option of further treatment following the extension
to the licence of letrozole (Femara) ...more
373 Adjunct radiotherapy
treatment challenged A five-year study of women aged 50 and
over, who had undergone surgery for early breast cancer, shows a substantially
lower rate of local relapse with local radiotherapy plus tamoxifen compared
with tamoxifen alone. However, overall survival at five years did not
differ significantly between the groups. The authors of this study question
the trend towards the use of adjuvant treatment with tamoxifen alone
in such women ...more
373 FIP wants
tobacco to be banned from all pharmacies Licensing authorities
should refuse to register pharmacies that operate from premises where
tobacco is sold, the International Pharmaceutical Federation (FIP) has
said ...more
373 First stress
incontinence drug launched Duloxetine (Yentreve) is the first
drug to be marketed for treatment of stress urinary incontinence (SUI)
in women ...more
373 MRSA studies
weak Interventions, including isolation, can achieve major
reductions in methicillin resistant Staphylococcus aureus, but no well
designed studies address isolation measures alone, say researchers who
have looked at 46 trials ...more
373 Trial registration Many
medical journals will soon require clinical trials to be registered in
a public trials registry as a condition of consideration for publication
...more
374 Half of epilepsy
patients have cognitive problems Almost half of patients with
epilepsy experience moderate to severe cognitive impairment due to their
condition or the drugs they are taking to control their seizures ...more
374 More fears
raised over valproate in pregnancy One in four women with
epilepsy who take sodium valproate during pregnancy will either have
a child with a physical congenital abnormality or a child who will suffer
significant neurodevelopmental delay, data show ...more
374 Study concludes
MMR vaccine “not associated with autism” MMR
vaccination is not associated with an increased risk of any pervasive
developmental disorder, or, specifically, autism. So concludes a matched
case control study involving data on over 5,000 children ...more
374 Scottish
Medicines Consortium issues advice on four products The Scottish
Medicines Consortium has issued new advice on atazanavir, buprenorphine,
Co-Diovan and rabeprazole this week ...more
374 Restless
legs syndrome Ropinirole (Requip) helps people with restless
legs syndrome, according to data presented at the European Federation
of Neurological Societies meeting last week ...more
374 Hepatitis
B vaccine linked to MS Hepatitis B vaccination has been linked
with a threefold increase in the risk of developing multiple sclerosis
(MS) ...more
374 1950s smallpox
vaccine In the event that large-scale smallpox vaccination
is needed, the efficacy of diluted doses of stockpiled vaccine is important
to determine, says a study in JAMA ...more
374 Global measures
to control TB The World Health Organization approach to controlling
tuberculosis, which focuses on short-course directly-observed therapy,
is not enough to curb the global problem, say doctors ...more
375 No advantage
over statins for ezetimibe, says DTB Ezetimibe (Ezetrol)
offers no compelling clinical advantage over, and should not replace,
a statin used by itself for routine cholesterol-lowering, according to
the Drug and Therapeutics Bulletin ...more
375 Galantamine
of no benefit in chronic fatigue syndrome Galantamine is of
no benefit over placebo for the treatment of chronic fatigue syndrome
(CFS), according to new study ...more
375 Fitness,
not fatness, predicts heart disease Fitness may be a better
predictor of heart disease than fatness in women, a new study suggests
...more
375 Cancer risk
is higher with some immunosuppressants Careful selection of
immunosuppressive agents is vital for transplant patients who either
have, or are considered at high risk of, developing cancer, concludes
a study presented at the International Transplantation Society meeting
in Vienna, Austria, last week ...more
375 Rosiglitazone
plus metformin combination improves glycaemic control in diabetes A “real-life” study
in type 2 diabetes has demonstrated that combination therapy with rosiglitazone
plus metformin (Avandamet) effectively lowers blood glucose levels and
reduces blood pressure ...more
|
The
Pharmaceutical Journal